Professor Remuzzi is Director of the Mario Negri Institute for Pharmacological Research, Milan, Italy.
From 2013 to 2015, he was President of the International Society of Nephrology (ISN) and creator of the ISN initiative called "0 by 25": Nobody should die of preventable and treatable Acute Kidney Injury (AKI) by 2025.
Prof. Remuzzi serves on editorial boards of numerous journals and is a member of the International Advisory Board of The Lancet. He served as Editorial Board member of the New England Journal of Medicine from 1998-2013. In recognition of his achievements, he has been awarded in 1998 honorary memberships of the Association of American Physicians and the British Royal College of Physicians.
He studies on immunologic mechanisms that influence the survival of transplanted organs, understanding of immunologic tolerance in the disorders that are linked to autoimmunity and finally, genetic diseases of the kidney have been areas of investigation. Giuseppe Remuzzi is investigating the kidney's ability to regenerate itself.
Prof. Remuzzi has authored and co-authored more than 1500 scientific articles, reviews and monographs and 19 books and regularly collaborate through the preparation of scientific articles with the Italian national newspaper “Corriere della Sera”.